Patricia Gauthier

Global Commercialization Lead, Rare Diseases and Latent Virus Consulate General of Canada (CTA Boston)

  • Boston MA

Patricia Gauthier is actively involved in organizations that are committed to rethinking innovation and inspiring leadership.

Contact

Consulate General of Canada (CTA Boston)

View more experts managed by Consulate General of Canada (CTA Boston)

Social

Biography

Patricia Gauthier joined Moderna at the end of 2020 as General Manager to set up and lead Moderna's Canadian organization. She played a key role in Moderna's response to the COVID-19 pandemic in Canada, and quickly established collaborative relationships with government and other life sciences stakeholders.

Before joining Moderna, Patricia spent 12 years at pharmaceutical giant GSK, holding key senior roles including Head of the Vaccines Business Unit and Head of Government Affairs and Market Access.

Patricia Gauthier's professional path has taken her to all corners of the world, living in the United States, Singapore and France, as well as London while working as a lawyer at McCarthy Tétrault. In addition to her legal studies, Patricia holds an MBA from HEC Montréal and certifications in strategic negotiation from Harvard Business School and in leadership from IMD.

Originally from Trois-Rivières, Patricia Gauthier has been based in Toronto for over a decade with her family. She is actively involved in organizations that are committed to rethinking innovation and inspiring leadership, like the Creative Destruction Lab, and from 2015-2019 she served as a board member of NEOMED, which fosters commercial opportunities for biotechnology innovations.

Industry Expertise

Pharmaceuticals
Health Care - Providers
Health Care - Facilities
Health Care - Services

Areas of Expertise

Pharmaceutical Sales
Government Affairs
Strategic Negotiations
COVID-19 Response Strategies
Vaccine Manufacturing

Education

HEC Montréal

MBA

2008

Université de Sherbrooke

LLB

Law

2001

Multimedia

Accomplishments

CGCA - Business Achievement Award

2022

Selected Media Appearances

We are updating the vaccine to target Omicron: President of Moderna Canada

Bloomberg  tv

2023-11-03

Patricia Gauthier, president and general manager at Moderna Canada, joins BNN Bloomberg to discuss how the company's updated vaccine will offer broader protection and last longer.

View More

MODERNA INITIATES ROLLING SUBMISSION TO HEALTH CANADA FOR UPDATED COVID-19 VACCINE

Yahoo! Finance  online

2023-06-29

"As the COVID-19 virus evolves, so must the vaccines. An updated vaccine will ensure Canadians have the most current and effective option to keep them protected. We have initiated our submission with Health Canada and, pending approval, will be ready to supply an XBB monovalent vaccine in time for the fall," said Patricia Gauthier, President and General Manager, Moderna Canada.

View More

Province announces $4M investment to bring mRNA vaccine production to Cambridge

CBC News  online

2023-05-04

"Today is a very important milestone in that commitment," said president of Moderna Canada, Patricia Gauthier.

"Moderna will now be able to deliver domestic ... mRNA vaccine production, ensuring Canadians have secure, on shore, direct access to our mRNA vaccines for future pandemic and health emergencies."

View More

Show All +